![John N. Abelson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John N. Abelson
Oprichter bij The Agouron Institute
Actieve functies van John N. Abelson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
California Institute of Technology
![]() California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | Corporate Officer/Principal | - | - |
The Agouron Institute | Directeur/Bestuurslid | - | - |
Oprichter | - | - |
Loopbaan van John N. Abelson
Eerdere bekende functies van John N. Abelson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Melinta Subsidiary Corp.
![]() Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT. | Oprichter | 01-10-2000 | - |
Statistieken
Internationaal
Verenigde Staten | 4 |
Operationeel
Founder | 2 |
Corporate Officer/Principal | 1 |
Director/Board Member | 1 |
Sectoraal
Health Technology | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Melinta Subsidiary Corp.
![]() Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT. | Health Technology |
The Agouron Institute |
- Beurs
- Insiders
- John N. Abelson
- Ervaring